Following a national search, Roswell Park Comprehensive Cancer Center has promoted Emese Zsiros, MD, PhD, FACOG, to lead its Department of Gynecologic Oncology. On staff at Roswell Park since 2014, Dr. Zsiros, an accomplished physician-researcher, will also hold The Shashi Lele, MD, Endowed Chair in Gynecologic Oncology.

In acknowledgment of strong advocacy for its staff members and the launch of a program to enhance their mental health and wellbeing, Roswell Park Comprehensive Cancer Center has been named a 2021 Joy in Medicine Recognized Organization by the American Medical Association (AMA).

A new study from Roswell Park has identified an important mechanism by which chronic stress weakens immunity and promotes tumor growth. The results, just published in Cell Reports, point to the beta-adrenergic receptor (β-AR) as a driver of immune suppression and cancer growth in response to stress, opening the possibility of targeting this receptor in cancer therapy and prevention.

A groundbreaking international collaboration brought an innovative lung cancer immunotherapy from Cuba — CIMAvax-EGF — to Roswell Park Comprehensive Cancer Center. Now researchers at the Buffalo-based center are now examining whether this immunotherapy developed to treat lung cancer might prove to be an effective tool for preventing the often-deadly disease.